Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-12-08

Clinical Trial Update: An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 study investigating the mechanism of action of Seretide (fluticasone propionate/salmeterol) in chronic obstructive pulmonary disease. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: University of Southampton | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED